Identification of candidate environmental risks for autism
Identification of candidate environmental risks for autism
批准号:
9525549
负责人:
Mark J. Zylka
金额:
$25.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2018-08-31
关键词:
AcuteAffectAutistic DisorderBehaviorBehavioralBirthBrainBrain DiseasesCerebral cortexChemicalsChronicDataDevelopmentDiseaseDoseElectron Transport Complex IIIEmbryoEnvironmental ExposureEnvironmental Risk FactorExposure toFoodFutureFuture GenerationsGene ExpressionGene Expression ProfileGene MutationGenesGeneticGenetic TranscriptionHeritabilityHistologicHumanIn VitroIndividualIndustrial fungicideJointsKnowledgeLifeLigationLinkMediatingMicrotubulesMitochondriaModelingMolecular ModelsMusMutationNeuroimmuneNeuronsOligonucleotidesOralPathologyPesticidesPhenotypePhysiologyPoisonPregnancyPrevalencePublic HealthRNAReactive Oxygen SpeciesRiskRoboticsSourceSynapsesSynaptic TransmissionTechnologyTestingUBE3A geneWild Type Mousebuilding materialscandidate identificationchemical groupcritical periodenvironmental chemicalexperimental studyexposed human populationin vivoinnovationmolecular modelingmouse modelneuroinflammationprenatalprospectivescreeningsocialtargeted sequencingtranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Heritability studies indicate that genetic and environmental factors contribute to autism risk. While new
sequencing technologies were used to identify hundreds of de novo gene mutations linked to autism, only a
small number of environmental risks for autism have been identified to date. Moreover, these environmental
risks were identified retrospectively, after a large number of people were exposed. There is thus a significant
public health need to identify environmental risks for autism prospectively, before these risks contribute to
disease. Brain transcriptional changes differentiate individuals with autism from neurotypical controls. This
transcriptional signature of autism is defined by reduced expression of synaptic transmission genes and
elevated expression of neuroimmune/microglial genes. Here, we hypothesize that candidate environmental
risks for autism can be prospectively identified using the transcriptional signature of autism as a
guide. We recently found that strobilurin fungicides reproducibly produce this transcriptional signature in
embryonic cortical neuron cultures, making these fungicides ideal chemicals to test this hypothesis. Strobilurin
fungicides poison mitochondrial complex III and, as we found, generate reactive oxygen species (ROS) and
destabilize microtubules in neurons. Usage of these fungicides is surging on a diversity of food crops and one
strobilurin is now being used in wallboards, posing a potential source for chronic exposure. Here we will
comprehensively evaluate the extent to which prenatal fungicide exposure produces autism-related
phenotypes in wild-type mice and exacerbates pathology in a new mouse line that models a human de novo
autism-linked mutation. We will use a low dose that approximates human exposures and a higher dose that
effects physiology and behavior when administered orally. To greatly accelerate the pace at which additional
environmental risks for autism are identified, we will transcriptionally profile thousands of environmental-use
chemicals on primary neuron cultures using an innovative targeted sequencing approach. We found that
primary neuron cultures model the molecular and cellular diversity of the intact brain. Our preliminary data
indicate this targeted sequencing approach can be performed robotically in 384-well dishes with cultured
primary neurons and can identify chemicals that produce the transcriptional signature of autism. This targeted
sequencing approach can also identify chemicals that produce transcriptional changes associated with other
brain disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a deep neural network to measure spontaneous pain from mouse facial expressions
-
批准号:10094266
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2020
-
负责人:Mark J. Zylka
-
依托单位:
Development of a deep neural network to measure spontaneous pain from mouse facial expressions
-
批准号:10579988
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2020
-
负责人:Mark J. Zylka
-
依托单位:
Development of a deep neural network to measure spontaneous pain from mouse facial expressions
-
批准号:10717670
-
项目类别:
-
资助金额:$3.97万
-
财政年份:2020
-
负责人:Mark J. Zylka
-
依托单位:
Development of a deep neural network to measure spontaneous pain from mouse facial expressions
-
批准号:10349447
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2020
-
负责人:Mark J. Zylka
-
依托单位:
CRISPR/Cas9-based gene therapy for Angelman syndrome
-
批准号:10490828
-
项目类别:
-
资助金额:$54.07万
-
财政年份:2019
-
负责人:Mark J. Zylka
-
依托单位:
CRISPR/Cas9-based gene therapy for Angelman syndrome
-
批准号:10237150
-
项目类别:
-
资助金额:$58.61万
-
财政年份:2019
-
负责人:Mark J. Zylka
-
依托单位:
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders
-
批准号:10402265
-
项目类别:
-
资助金额:$85.2万
-
财政年份:2019
-
负责人:Mark J. Zylka
-
依托单位:
Environmental-use chemicals that target pathways linked to autism and other neurodevelopmental disorders
-
批准号:10618242
-
项目类别:
-
资助金额:$85.2万
-
财政年份:2019
-
负责人:Mark J. Zylka
-
依托单位:
CRISPR/Cas9-based gene therapy for Angelman syndrome
-
批准号:10011898
-
项目类别:
-
资助金额:$56.99万
-
财政年份:2019
-
负责人:Mark J. Zylka
-
依托单位:
Lipid kinase regulation of pain signaling and sensitization
-
批准号:9279273
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:Mark J. Zylka
-
依托单位:
The Elongation Hypothesis of Autism
-
批准号:8899547
-
项目类别:
-
资助金额:$76.0万
-
财政年份:2013
-
负责人:Mark J. Zylka
-
依托单位:
Lipid kinase regulation of pain signaling and sensitization
-
批准号:8627903
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:Mark J. Zylka
-
依托单位:
The Elongation Hypothesis of Autism
-
批准号:8560195
-
项目类别:
-
资助金额:$76.0万
-
财政年份:2013
-
负责人:Mark J. Zylka
-
依托单位:
Lipid kinase regulation of pain signaling and sensitization
-
批准号:8723315
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2013
-
负责人:Mark J. Zylka
-
依托单位:
Harnessing ectonucleotidases to treat chronic pain
-
批准号:7763510
-
项目类别:
-
资助金额:$71.68万
-
财政年份:2009
-
负责人:Mark J. Zylka
-
依托单位:
Harnessing ectonucleotidases to treat chronic pain
-
批准号:8541896
-
项目类别:
-
资助金额:$70.82万
-
财政年份:2009
-
负责人:Mark J. Zylka
-
依托单位:
Harnessing ectonucleotidases to treat chronic pain
-
批准号:8144264
-
项目类别:
-
资助金额:$73.05万
-
财政年份:2009
-
负责人:Mark J. Zylka
-
依托单位:
Harnessing ectonucleotidases to treat chronic pain
-
批准号:8332859
-
项目类别:
-
资助金额:$73.03万
-
财政年份:2009
-
负责人:Mark J. Zylka
-
依托单位:
BAC Technology
-
批准号:7620183
-
项目类别:
-
资助金额:$18.59万
-
财政年份:2008
-
负责人:Mark J. Zylka
-
依托单位:
Biochemical Modulation of Nociceptive Circuits
-
批准号:7347513
-
项目类别:
-
资助金额:$31.71万
-
财政年份:2007
-
负责人:Mark J. Zylka
-
依托单位:
海外基金